Kenny Lim
Mar 4, 2010

VIDEO: John Cahill, president of McCann Healthcare APAC, on the empowered health consumer

SINGAPORE - At a recent roundtable with clients from GlaxoSmithKline and Roche Diagnostics among others, John Cahill (pictured), president of McCann Healthcare Worldwide EMEA and APAC, gave insights into the rapidly evolving and growing healthcare industry as well as the changing face of communications in the region.

John Cahill president of McCann Healthcare APAC
John Cahill president of McCann Healthcare APAC
Cahill also touched on why healthcare brands are less enduring than consumer brands in general. He says: “It’s technological. We’re constantly seeing new molecules come out to treat diseases that are improvements upon their previous molecules.”

“Because health is such an important issue, to leave patients with an inferior molecule when there is a better outcome available wouldn’t be ethical."

Cahill adds that unlike consumer brands, where the purchaser is the consumer himself, there are other intermediaries in healthcare that make the purchasing decisions. Invariably, the patient is a passive receiver of the doctor’s decision.

“The doctor then also has to somehow engage the patient to get them to understand why they are taking the brand and to continue with its usage,” says Cahill.

On creating the “empowered health consumer”, the McCann Healthcare Worldwide chief defines this as the ‘Holy Grail’ of healthcare communications.

Cahill then elaborates on how most health systems tend to alienate consumers with jargon and information they cannot understand. Subsequently, more and more worldwide health organisations are attempting to bring consumers to higher levels of health awareness.


 

Related Articles

Just Published

4 days ago

Publicis climbs the highest in APAC media rankings ...

PHD retains the overall lead, as Omnicom Media Group sees an end-of-year boost from Tata Motors' win, and Publicis Media rockets to the sixth spot.

Dec 23, 2024

Netflix is going all out for Squid Game season ...

With a Golden Globe nomination secured even before its release, the record-breaking series returns on December 26, backed by Netflix’s boldest marketing push yet.